Print this page

Personalized Oncology Promoting Equity for Black Lives (PROPEL).

The specific aims of this study are: 1) Test the efficacy of a culturally tailored and interactive electronic relational agent (RA) intervention vs. enhanced usual care (EUC) consisting of clinical letter and genetic recommendation on engagement in genetic education and genetic testing uptake; 2) Evaluate the impact of the RA vs. EUC on informed decision-making and psychosocial outcomes; and 3) Explore potential mechanisms by assessing mediators and moderations of efficacy.

Protocol Number: 132309
Phase: N/A
Applicable Disease Sites: Breast
Colon
Corpus Uteri
Ovary
Pancreas
Prostate
Principal Investigator: Anita Y Kinney
Scope: National
Participating Institutions:
  • Georgetown Lombardi Comprehensive Cancer Center
  • MedStar Washington Cancer Institute
  • Rutgers University
  • RWJBarnabas Health
    • Community Medical Center
    • Clara Maass Medical Center
    • Cooperman Barnabas, Livingston
    • Jersey City Medical Center, Jersey City
    • Monmouth Medical Center
    • Monmouth Medical Center Southern Campus
    • Newark Beth Israel Medical Center
    • Robert Wood Johnson University Hospital, Hamilton
    • Robert Wood Johnson University Hospital, New Brunswick
    • Robert Wood Johnson University Hospital, Rahway
    • Robert Wood Johnson University Hospital, Somerset
    • Trinitas Hospital and Comprehensive Cancer Center
Inclusion & Exclusion Criteria ►

Please note that we have obtained the inclusion and exclusion criteria information from the National Institutes of Health’s clinical trials web site ClinicalTrials.gov. The listed criteria may not necessarily reflect recent amendments to the protocol and the current criteria.

For further information about clinical trials, please contact us at 732-235-7356.